泰林生物(300813) - 泰林生物调研活动信息

Company Overview - Zhejiang Tailin Biological Technology Co., Ltd. was listed on the Shenzhen Stock Exchange in January 2020 as a high-tech enterprise focused on life science system solutions [1] - The company specializes in biotechnology, precision medicine, pharmaceutical engineering, food safety, and new materials, providing a comprehensive range of equipment, precision instruments, and consumables [1] Client Base and Market Reach - The company serves thousands of clients across various sectors, including pharmaceutical companies, food and drug inspection agencies, healthcare institutions, and research units [2] Production Capacity - As of now, the company operates three production bases located in Binjiang headquarters, Fuyang No. 7 Road Park, and Fuyang No. 2 Road Park [2] - The Binjiang headquarters focuses on the R&D and production of organic analysis products, while the Fuyang No. 7 Road Park specializes in microbiological testing technology [2] Research and Development - The company holds over 330 national patents and nearly 70 software copyrights, participating in the formulation of 27 national and industry standards [2] - Future R&D will focus on "domestic innovation, import substitution, and high-end positioning," emphasizing independent innovation [2] Cell Therapy Developments - In 2022, the company made progress in the field of cell and gene therapy, enhancing its product line and developing solutions for cell preparation and automated production equipment [2]